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Objective. To evaluate bronchial challenges using three different stimuli as screening tools for bronchial hyper-responsiveness in sulfur
mustard gas-induced asthma. Design. Randomized, cross-over clinical study. Setting. University hospital. Patients. Eighteen veterans
with mustard gas-induced asthma and 18 normal veterans as the control group. Intervention. Pulmonary function tests and inhalation
challenges with ultrasonically nebulized distilled water (UNDW), methacholine, and ultrasonically nebulized cold water (UNDCW) were
performed on all patients and subjects. Results. Six mustard gas-induced asthmatic veterans did not respond to a 20% in FEV1 after
distilled water (13.3%), and two of them (11.11%) did not respond with distilled cold water; all responded with methacholine. Only one
healthy subject developed a PC20 FEV1 after methacholine but did not with both distilled water and distilled cold water challenges. The
asthmatic patients were sensitive to distilled water with a median PD20 of 7.24 ± 3.83 ml (range 2.54 ml to 15.83 ml), and sensitive to cold
water with a median PD20 of 6.42 ± 6.24 ml (range 1.92 ml to 25.15 ml). The median PC20 methacholine was 1.90 ± 1.88 mg/ml (range
0.14 mg/ml to 6.20 mg/ml). In patients with a positive response to the distilled water challenge test, no significant correlation was found
between PC20 of methacholine and PD20 of distilled water (Rho = −0.34, p = 0.25), whereas in patients whose responses to distilled
cold water (DCW) were positive, PD20 of distilled cold water (DCW) correlated well with PC20 of methacholine (Rho = −0.69, p =
0.006). Conclusion. Overall, the methacholine challenge test is the best method to distinguish these asthmatic patients from normal
subjects in this study. When compared to the methacholine challenge, although the airway response to ultrasonically nebulized distilled
cold water test was somewhat less sensitive, it may be used as a simple, fast, inexpensive, and relatively reliable method to predict the
absence of asthma in sulfur mustard gas-induced asthma.
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Introduction
Sulfur mustard gas is used as a vesicant chemical warfare
agent (1). This chemical gas is an alkylating agent that is
acutely toxic to the skin, eyes, and respiratory system (2–4).
Upper and lower respiratory tracts may be acutely damaged
after its inhalation (3,5,6). The diversity of the effects of sul-
fur mustard gas inhalation upon the respiratory system has
been investigated following a single and heavy exposure in
Iranian veterans (2). Bronchial hypersensitivity and asthma
may occur as an important chronic sequella of the manifesta-
tion of sulfur mustard gas inhalation (2,7).
On the other hand, bronchial hyper-responsiveness is a
characteristic of patients with bronchial asthma (19). Metha-
choline challenge testing is a well-established means of
evaluating the degree of airway responsiveness (14,15). Non-
pharmacological challenge tests involve provocation with
cold air, exercise, and inhalation of isotonic and nonisotonic
aerosols (24,26,29). In general, these methods provide a high
specificity but somewhat less sensitivity. Since there are no
reports on the behavior response of airway hyper-reactivity to
a variety of stimuli in asthmatic veterans who have been
exposed to an acute and heavy exposure of sulfur mustard
gas, this study was carried out to define its pattern. The pur-
pose of the current investigation was to investigate and com-
pare the responses to inhaled methacholine, ultrasonically
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nebulized distilled water, and ultrasonically nebulized dis-
tilled cold water in mustard gas-induced asthma.
Methods
Patients with mustard gas-induced asthma
The study population consisted of two groups of non-smoking
veterans. The group of asthmatic subjects studied whose expo-
sure to mustard gas has been previously confirmed by studies
on their urine and vesicular fluid consisted of 18 non-smoking
veterans. They were aged 30–41 years (38.50 ± 3.58). All
patients had an absence of preceding respiratory symptoms and
pre-exposure asthma. None of the patients had a family history
of atopy or asthma. Patients with proven cardiovascular dis-
eases and those with exposure to other environmental or phar-
macological agents known to cause extrinsic allergic alveolitis,
and cases with evidence of recent infection or exacerbation of
their diseases were excluded. Overall, asthma was diagnosed in
21 cases as a late sequela of pulmonary effects of sulfur mus-
tard gas exposure. Three patients were excluded according to
our exclusion criteria. The initial pulmonary, skin, and eye
symptoms in these victims in 1986 following sulfur mustard
gas exposure are seen in Table 1. Baseline characteristics of the
asthmatic subjects are presented in Table 2. The diagnosis of
asthma was made when they met at least two of the following
criteria: 1) diurnal variability in peak expiratory flow (PEF)
rate >20% (8,9); 2) the reversibility of FEV1 as described by
Ries et al. (10); and 3) typical history of attacks of dyspnea,
wheezing, or both, nocturnal cough either spontaneously or
triggered by irritants, respiratory infections, or exercise.
All patients in this study used β2-agonists inhaled as needed.
Seven patients used inhalers beclomethasone diproprionate on
a regular basis, and five cases required daily inhaled bronchod-
ilator. None required systemic corticosteriods to control their
asthma. None were allowed to receive inhaled β2-agonist,
inhaled ipratropium bromide for 8 h, theophylline and inhaled
beclomethasone for four days prior to the study.
Normal controls (control group)
Eighteen sex- and age-matched healthy subjects with a mean
age of 36.16 ± 5.46 years old, with no history of upper or
lower respiratory tract symptoms served as a control group.
These healthy male veterans had been in combat zones but
not exposed to chemical agents. They had normal pulmonary
function parameters. Cases with a family history of asthma or
other allergic respiratory disorders were excluded. There was
no history of respiratory tract infection during the four weeks
prior to the study. Overall, 22 non-sulfur mustard gas-
exposed veterans (as the control group) were recruited during
a one month period and four of them were excluded accord-
ing to our exclusion criteria.
Study design
At the time of the study, all veterans had been free of symp-
toms of any respiratory illness for four weeks. The FEV1 was
more than 70% of predicted normal at entry of the study.
The study protocol consisted of inhalation challenges with
ultrasonically nebulized distilled water, methacholine, and
ultrasonically nebulized cold water. The challenges were
performed at the same time of day for each subject, within
10 days and at least two days apart. The persons administrat-
ing the intervention were blinded to the group assignment.
The study was a randomized, cross-over study. Normal sub-
jects and patients were randomly assigned to start with either
ultrasonically nebulized distilled water, methacholine, or
ultrasonically nebulized distilled cold water.
All cases were initially examined at time of entry to our
pulmonary lab. They rested for 30 minutes before testing. All
cases signed an informed written consent and had a complete
history and physical examination.
Measurement of pulmonary function
Pulmonary function tests were performed at each visit. These
tests were measured through spirometric assessment accord-
ing to the standards advocated by the American Thoracic
Society (11). An experienced physician conducted all spiro-
metric measurements for all subjects using FUDAC 50
(Fukunda Sangyo Co., LTD, Japan). Each patient was well
trained to give his best effort. Results were expressed as per-
centage-predicted based on accepted reference standards
(12,13). The highest values were chosen and reported.
Challenge with ultrasonically nebulized distilled water 
(UNDW)
Aerosols of room-temperature distilled water were generated
by an ultrasonic nebulized (Heyer Orion 1, BAD EMS). Its
mean output was 2.40 ml/min. Oral inhalation was ensured
by using nose clips. Following baseline spirometric measure-
ments, the subjects were instructed to inhale the mist from a
Table 1. Initial pulmonary, eye, and skin symptoms in patients with
sulfur mustard gas-induced asthma in 1986
Number of
patients
Pulmonary Cough 18
Dyspnea at rest 18
Chest tightness 16
Wheeze 0
Pulmonary infiltration 0
Skin Blister and bulla 16
Erythema 16
Eye Photophobia 15
Lacrimation 15
Lid edema 15
Conjunctivitis 15Bronchial responsiveness in asthmatic patients 567
facemask at tidal breathing (15 to 20 times/min). Inhalation
of the aerosol was initiated with 1.3 ml. The patients inhaled
increasing volumes of UNDW until FEV1 was reduced by
20% from baseline value, or the water dose exceeded 34.8 ml
(14,15). The cumulated dose of delivered nebulized water
producing a 20% fall in FEV1 (PD20 UNDW) was calculated
by linear interpolation on the dose-response curve.
Challenge with methacholine
The aerosols of methacholine was generated from a DeVil-
biss no 45 nebulized operated by compressed air at 50 ib/in2
and a flow rate of 5 l/min to give an output of 0.156 ml/min.
They were delivered through the mouth while the subjects
were wearing a nose clip by five slow vital capacity maneuvers,
each separated by a five second breath hold. At first, the sub-
jects were asked to inhale from a phosphate buffered saline.
Then, the aerosols of methacholine solutions were nebulized
at five minute intervals by a two-fold-increasing concentra-
tion of methacholine (0.03 − 25 mg/ml). Spirometric values
were determined before and 0.5 and 1.5 minutes after each
dose. The challenge was stopped after reaching the concen-
tration of methacholine that provoked a 20% reduction in
forced expiratory volume in one second (FEV1) from pre-
challenge baseline (PC20 M). The provocative concentrations
of methacholine required to produce a 20% fall in FEV1 from
the post-saline FEV1 (PC20) was calculated by interpolation.
Challenge with ultrasonically nebulized distilled cold 
water (UNDCW)
The method of this challenge test was similar to provocation
with ultrasonically nebulized distilled water, as previously
described. In this procedure, the water canister was filled
with cold water (4°C). A constant water temperature was
maintained by adding ice cubes to the canister after each
challenge test. The patients inhaled increasing volumes of
UNCDW until FEV1 was reduced by 20% from baseline
value or the water dose exceeded 34.8 ml. The provocative
cumulated dose of delivered cold nebulized water producing
a 20% fall in FEV1 (PD20 UNCDW) was calculated by linear
interpolation on the dose-response curve.
Statistics
All results are mean ± SD unless otherwise indicated. Com-
parisons between the study groups were performed using the
Mann–Whitney U test. Correlations between different param-
eters were determined by Spearman’s rank correlation
Table 2. Results of baseline FEV1 measurements, PC20 (mg/ml), PD20 of distilled water (ml), and PD20 of distilled cold water (ml) in
patients with mustard gas-induced asthma
Age
Methacholine UNDW* UNDCW*
Baseline 
FEV1, % PC20 (mg/ml)
Baseline 
FEV1, % PD20 (ml)
Baseline 
FEV1, % PD20 (ml)
1 38. 76.4 .14 81.4 2.54 88.1 1.92
2 43. 92.9 3.5 101.9 NR** 90.5 6.58
3 38. 91.5 .49 81.2 10.050 85.3 2.85
4 37. 90.3 2.6 88.1 NR** 78.3 4.19
5 36. 97.1 1.2 88.1 5.77 106.1 3.16
6 44. 94.3 .87 90.3 NR** 94.8 NR**
7 43. 88.5 .40 93.2 9.260 86.7 3.75
8 36. 89.5 5.8 99.7 NR** 85.9 25.15
9 32. 84.2 .83 95.8 6.73 98.6 5.63
10 35. 84.2 .21 87.4 2.71 89.9 4.20
11 33. 82.7 1.9 89.3 4.79 79.5 3.56
12 36. 98.7 .47 90.8 NR** 95.5 NR**
13 44. 93.5 6.2 97.9 15.83 85.1 14.33
14 40. 85.2 .18 96.5 8.15 82.3 2.47
15 41. 76.8 1.6 80.3 NR** 83.9 14.20
16 39. 81.3 2.4 75.4 11.01 89.1 3.91
17 38. 83.5 1.3 80.2 5.67 98.4 2.38
18 40. 86.8 4.12 102.3 4.44 80.2 4.59
Mean ± SD 38.50 ± 3.58 87.63 ± 6.41 1.90 ± 1.88 89.98 ± 8.06 7.24 ± 3.83*** 88.78 ± 7.47 6.42 ± 6.24****
*UNDW=nebulized ultrasonic distilled water, UNCDW=nebulized ultrasonic distilled cold water.
**NR=negative response.
***Mean± SD in those with positive response to DW.
**** Mean± SD in those with positive response to DCW.568 A. Emad and Y. Emad
coefficient. Logarithmic transformations were applied to all val-
ues for PD20 UNDW, PC20 M, and PD20 UNDCW before com-
parison. p values of less than 0.05 were regarded as significant.
Results
The initial pulmonary, skin, and eye symptoms in these vic-
tims in 1986 following sulfur mustard gas exposure are seen
in Table 1. All mustard-gas induced asthmatic patients in this
study who survived a short-term and massive sulfur mustard
gas exposure recovered within a few weeks in 1986. How-
ever, they developed episodic wheeze, breathlessness, chest
tightness, or cough and variable airflow obstructive pattern in
pulmonary function tests spontaneously or from many and
varied environmental stimuli following the initial gas expo-
sure. All had a diurnal variability in PFT rate. A reversibility
of FEV1 was also noted in all subjects of the group of asthma.
There was no significant difference between the mean age
of the control subjects (36.16 ± 5.46) with the asthmatic
group (38.50 ± 3.58) (p = 0.18). The results of the challenge
tests for the asthmatic veterans are summarized in Table 2.
Baseline FEV1 measurements (as percent predicted) were not
significantly different between the normal subjects and asth-
matics at the beginning of all challenge tests. No significant
difference between baseline FEV1 (as percent predicted) on
the three challenge days was found (p = 0.12, 0.2, 0.08,
respectively).
Six mustard gas-induced asthmatic veterans did not sustain
a 20% in FEV1 after ultrasonically nebulized distilled water
(33.3%), and two of them (11.11%) did not with ultrasoni-
cally nebulized distilled cold water; all did with methacho-
line. In other words, all mustard gas-induced asthmatics were
sensitive to the methacholine challenge test. Sixteen patients
were sensitive to the UNDCW challenge test, but only
12 patients responded to ultrasonically nebulized distilled
water (UNDW).
Only one healthy subject developed a PC20 FEV1 after
methacholine (PC20 methacholine = 18.25 mg/ml). The
PC20 methacholine in the rest of healthy cases was >25 mg/
ml. No control group responded to both ultrasonically dis-
tilled water and ultrasonically distilled cold water challenges.
The asthmatic patients were sensitive to distilled water
with a median PD20 of 7.24 ± 3.83 ml (range 2.54 ml to
15.83 ml) and sensitive to cold water with a median PD20 of
6.42 ± 6.24 ml (range 1.92 ml to 25.15 ml). The median PC20
methacholine was 1.90 ± 1.88 mg/ml (range 0.14 mg/ml to
6.20 mg/ml). No correlation between PC20 of methacholine
and baseline FEV1 was seen (Rho = −0.17, p = 047).
In patients with a positive response to the distilled water
challenge test, no significant correlation was found between
PC20 of methacholine and PD20 of distilled water (Rho = −0.34,
p = 0.25) (Fig. 1).I In patients whose responses to distilled
cold water (UNDCW) were positive, PD20 of distilled cold
water (UNDCW) correlated well with PC20 of methacholine
(Rho = −0.69, p = 0.006) (Fig. 2).
Discussion
Sulfur mustard gas may shed the columnar cells of the epithe-
lial lining of the upper respiratory tract in an acute heavy
exposure. This event may be accompanied by peribronchial
edema, hyperemia of the blood vessels, cellular infiltrations
in the submucosa, and serious vacuolization and disorganiza-
tion of cytoplasma and nuclear structures (16,17). Bronchial
hypersensitivity and asthma may be due to the direct conse-
quence of these cytotoxic and inflammatory effects of this
toxic gas (18).
Airway hyper-responsiveness is a characteristic and key
feature of asthma (19). Clinically, and for research purposes,
responsiveness to an administered drug or compound
Fig. 1. A) Comparison of responses to provocative concentration of
methacholine causing a 20% fall in FEV1 (PC20 M) and
provocative dose of distilled water causing a 20% fall in FEV1
(PD20 UNDW) values in patients with a positive response to
ultrasonically nebulized distilled water (UNDW). B) Comparison
of PC20 M and PD20 UNDW values in patients with PC20 ≤ 6 mg/
ml and PD20 UNDW ≤ 12 ml.
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remains the most useful physiological test in the assessment
of asthma (20). In this study, we have evaluated bronchial
challenge using three different stimuli as screening tools
for bronchial hyper-responsiveness in sulfur mustard gas-
induced asthma for the first time. The obtained data were
compared.
The applied tests in this study (methacholine and UNDCW)
were shown to have accepted sensitivity screening tests in the
selected mustard-gas induced asthma. It is obvious that these
tests (alone) will discriminate between the other consequences
of sulfur mustard gas exposition such as chronic bronchitis,
fibrosis, and bronchiectasis. Additional interventions such as
BAL, computed tomographic (CT) scan of the chest, pulmo-
nary function test with restrictive ventilatory defect, diffusing
capacity of carbon monoxide (Dlco), and histological find-
ings will be helpful for the diagnosis of other consequences
of sulfur mustard gas exposition, like pulmonary fibrosis and
bronchiectasis.
In our study, all mustard gas-induced asthmatic patients
were sensitive to methacholine (100%). This study has shown
that bronchial hyper-responsiveness to methacholine has no
correlation with baseline % FEV1 values in patients with sul-
fur mustard-gas asthma. Overall, the methacholine challenge
test was the best method to distinguish these asthmatic
patients from the normal subjects in this study. This sugges-
tion is not different from the other non-mustard gas-induced
asthmatic cases with other studies (21,22).
Only 12 subjects (66.7%) from all mustard gas-induced
asthmatics were sensitive to ultrasonically nebulized distilled
water (DW). Therefore, the sensitivity of the airway response
to UNDW challenge (66.7%) is relatively low as compared to
that of methacholine (100%). No significant correlations
were found between PC20 of methacholine and PD20 of dis-
tilled water (Rho = −0.34, p = 0.25). This finding may indi-
cate that UNDW may act via a different pathway or
mechanism to cause bronchoconstriction in our patients as
compared to methacholine challenge. These findings are
similar to other previous reports about non-mustard gas-
induced asthma (21).
Interestingly, 16 of 18 cases of mustard gas-induced asth-
matics were sensitive to ultrasonically nebulized distilled
cold water (UNDCW). There was also a significant correla-
tion between PC20 of methacholine and PD20 of distilled
cold water (Rho = −0.56, p = 0.02). It is evident that sensitiv-
ity for UNDCW (88.9%) was less than that for methacholine
(100%) in revealing airway hypersensitivity in sulfur mustard
gas-induced asthma. The data showed that the positive and
negative predictive values of UNDCW for diagnosis or
exclusion of mustard gas-induced asthma were 100% in this
study. This challenge test was well tolerated by all patients,
whereas three patients had mild side effects with methacho-
line (increase water secretion, asthmatic attack).
This study verifies that ultrasonically nebulized distilled
cold water (UNDCW) challenge is a potent stimulus to cause
airway narrowing (23–26). Other studies believe that cold
and dry air may cause airway narrowing through the release of
leukotrienes (27). Airway smooth muscle can be constricted
directly by agonists, such as methacholine or histamine, which
activate receptors on the smooth-muscle cells, or by indirect
mechanisms, such as cold air or exercise, which, at least in
part, induce the release of bronchoactive mediators from mast
cells (28,29).
In conclusion, as compared to methacholine challenge,
although the airway response to the UNDCW test was some-
what less sensitive, our results demonstrate that it seems that
UNDCW may be used as a simple, fast, inexpensive (the cost
of the use of the methacholine test is about $100, whereas the
UNDCW test is about $30 in Iran), and relatively reliable
method to predict the absence of asthma in sulfur mustard
gas-induced asthma.
Fig. 2. A) Comparison of responses to provocative concentration of
methacholine causing a 20% fall in FEV1 (PC20 M), and
provocative dose of distilled cold water causing a 20% fall in FEV1
(PD20 UNDCW) values in patients with a positive response to
ultrasonically nebulized distilled cold water (UNDCW). B)
Comparison of PC20 M and PD20 UNDCW values in patients with
PC20 ≤ 8 mg/ml and PD20 UNDCW ≤ 12 ml.
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